A computerized reminder system improves compliance with Papanicolaou smear recommendations in an HIV care clinic

International Journal of STD and AIDS

Volumn 14, Issue 10, 2003, Pages 675-680

  Shuter, Jonathan ^a   Kalkut, Gary E ^a   Pinon, Miriam W ^a   Bellin, Eran Y ^a,b   Zingman, Barry S ^a  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b AIDS Center ^*  (United States)

Author keywords

Computer; Pap smear; Reminder; Screening

Indexed keywords

ADULT; ARTICLE; AUTOMATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT COMPLIANCE; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL;

ADULT; APPOINTMENTS AND SCHEDULES; COMPUTERS; DIAGNOSTIC TESTS, ROUTINE; FEMALE; HIV INFECTIONS; HUMANS; NEW YORK CITY; OUTPATIENT CLINICS, HOSPITAL; PATIENT COMPLIANCE; PREVALENCE; REMINDER SYSTEMS; UTERINE CERVICAL DISEASES; VAGINAL SMEARS;

EID: 0141748338     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646203322387938     Document Type: Article

References (26)

1. Bradbeer C. Is infection with HIV a risk factor for cervical intraepithelial neoplasia? Lancet 1987;2:1277-8
2. Feingold AR, Vermund SH, Burk RD, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J AIDS 1990;3:896-903
3. Cu-Uvin S, Hogan JW, Warren D, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. Clin Infect Dis 1999;29:1145-50
4. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997;337:1343-9
5. Ahdieh L, Munoz A, Vlahov D, Trimble CL, Timpson LA, Shah K. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 2000;151:1148-57
6. Williams AB, Darragh TM, Vranizan K, Ochia C, Moss AR, Palefsky JM. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994;83:205-11
7. Wright TC, Ellerbrock TV, Chiasson MA, VanDevanter N, Sun XW. Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. Obstet Gynecol 1994;84:591-7
8. Klein RS, Ho GYF, Vermund SH, Fleming J, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis 1994;170:1404-9
9. Chin KM, Sidhu JS, Janseen RS, Webber JT. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients. Obstet Gynecol 1998;92:83-7
10. Centers for Disease Control and Prevention. 1998 guidelines for treatment of sexually transmitted diseases. MMWR Recommendations and Reports 1998;47(RR-1):98
11. USPHS/IDSA Prevention of Opportunistic Infections Working Group. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Clin Infect Dis 2000;30:S29-65
12. Gross PA, Asch S, Kitahata MM, et al. Performance measures for guidelines on preventing opportunistic infections in patients infected with human immunodeficiency virus. Clin Infect Dis 2000;30:S85-93
13. McDonald CJ, Hui SL, Smith DM, et al. Reminders to physicians from an introspective computer medical record: a randomized two-year trial. Ann Intern Med 1984;100:130-8
14. Shea S, DuMouchel W, Bahamonde L. A meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc 1996;3:399-409
15. Maiman M. Management of cervical neoplasia in human immunodeficiency virus-infected women. J Natl Canc Inst Monog 1998;23:43-9
16. Goldie SJ, Weinstein MC, Kuntz KM, Freedberg KA. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women. Ann Intern Med 1999;130:97-101
17. Solomon L, Stein M, Flynn C, et al. Health services use by urban women with or at risk for HIV-1 infection: The HIV epidemiology research study (HERS). J AIDS 1998;17:253-61
18. Kaplan JE, Parham DL, Soto-Torres L, et al. Adherence to guidelines for antiretroviral therapy and for preventing opportunistic infections in HIV-infected adults and adolescents in Ryan White-funded facilities in the United States. J AIDS 1999;21:228-35
19. Stein M, Cunningham WE, Nakazono T, et al. Screening for cervical cancer in HIV-infected women receiving care in the United States. J AIDS 2001;27:463-6
20. Vonau BU, Boag F, Barton SE. Audit of cervical screening and colposcopy in HIV-positive women at a central London teaching hospital. Int J STD AIDS 1999;10:755-8
21. Ravet J. Pap smear reminder systems. Med J Austral 1992;156:663
22. Morgan MM, Goodson J, Barnett GO. Long-term changes in compliance with clinical guidelines through computer-based reminders. Proc AMIA Symp 1998:493-7
23. Tape TG, Campbell JR. Computerized medical records and preventive health care: Success depends on many factors. Ann Intern Med 1993;94:619-25
24. Litzelman DK, Dittus RS, Miller ME, Tierney WM. Requiring physicians to respond to computerized reminders improves their compliance with preventive care protocols. J Gen Intern Med 1998;8:311-17
25. Campbell E, Peterkin D, Abbott R, Rogers J. Encouraging underscreened women to have cervical cancer screening: the effectiveness of a computer strategy. Prevent Med 1997;26:801-7
26. Kania C, Richards R, Sanderson-Austin J, Wagner J, Wetzler H. Using clinical and functional data for quality improvement in outcomes measurement consortia. Jt Comm J Qual Improv 1996;22:492-504